Merck to cut 1,200 sales jobs

Share this article:
Merck announced plans to cut 1,200 sales jobs in the US. The layoffs follow an FDA rejection of Cordaptive, a cholesterol drug that was to be packaged with Zocor, and weak sales of Vytorin following the ENHANCE controversy.
Share this article:

Email Newsletters

More in Business Briefs

Social media perceived as clinical trial risk

The Wall Street Journal reports that patients are sharing a plethora of information about their clinical trial experiences, from how to get picked, to how to figure out who is in a control group.

Cancer PSA features scientists

Stand Up To Cancer is kicking off a PSA that features Grammy-winner Jennifer Hudson and a Genentech scientist.

Lawmakers eye pricing

The Senate Judiciary Committee's antitrust panel is looking into how three major pharmaceutical manufacturers decided to set minimum prices for their contact lenses.